Gradientech AB

Gradientech is a Swedish in vitro diagnostics company that develops and provides next-generation diagnostics solutions for ultra-rapid antibiotic susceptibility testing (AST). The company's core product, QuickMIC, is a system that speeds up blood diagnostics and supports better sepsis patient management by providing precise Minimum Inhibitory Concentration (MIC) values directly from positive blood cultures in just 2-4 hours. This enables clinicians to make faster, informed treatment decisions, reducing healthcare costs and the spread of antibiotic resistance. Gradientech's mission is to supply high-quality products that facilitate workflows for time-critical samples, such as positive blood cultures, and support clinicians in providing precision medicine for a sustainable world.